Severo et al. 1 reported that percentage flow-mediated dilation (FMD%) was lower in steroid users vs. nonusers. I would be grateful if the authors could clarify some aspects of their data presentation as well as comment on the fundamental influence of the baseline arterial diameter on their data.
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Severo et al. 1 reported that percentage flow-mediated dilation (FMD%) was lower in steroid users vs. nonusers. I would be grateful if the authors could clarify some aspects of their data presentation as well as comment on the fundamental influence of the baseline arterial diameter on their data.
Normally distributed data were said to be expressed as mean AE SD, yet I suspect that the data presented for FMD% are in fact mean AE SE. The error bars presented in Figure 1 equate to approximately 1.5%, which does not really tally with the range of FMD% values presented in Figure 2 (approximately 15% in both samples).
Also, in Figure 1 , the mean FMD% of users and nonusers is reported to be 2.2 and 7.4%, respectively. Yet in the text, the mean FMD% is reported to be 2.4% and 6.7% for users and non-users. Please could the authors indicate which set of mean FMD% values are correct.
Lastly, it was surprising not to see any information reported for the baseline arterial diameter of the cohorts. Atkinson et al. 2 
and Atkinson and Batterham 3 have recently shown how the dependency of FMD% on baseline diameter can compromise
estimates of the flow-mediated response. Perhaps Severo et al. 1 could use the allometric approach that is detailed in these publications (SPSS steps can be found in a supplementary file). With this approach, differences in the flow-mediated response between cohorts can be estimated, while the influence of baseline artery diameter is fully accounted for.
